Cheilectomy Market Insights by Medication, Type & Players Sanofi, Janssen Pharmaceuticals, Inc., Purdue Pharma ALLERGAN Republic of Ireland Research Report 2023

Global Cheilectomy Market research report: by method (open, arthroscopic, percutaneous) anesthesia (general, local, and regional anesthesia) medication (prescription pain relievers, NSAIDs) end-users (academic institutes, clinics) – Forecast till 2023

The global cheilectomy market is expected to grow at a CAGR of 7.8% during the forecast period.

KEY PLAYERS FOR CHEILECTOMY MARKET

Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.

Requested For Sample Report: https://www.marketresearchfuture.com/sample_request/5470 .

MARKET SCENARIO FOR CHEILECTOMY MARKET

Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more. Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1.  Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market. According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period.

SEGMENTATION FOR CHEILECTOMY MARKET

The global cheilectomy market is segmented by the method, anesthesia, medication, and end-user.

By the method, the market is segmented into open, arthroscopic, and percutaneous method.

By the anesthesia, the market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

REGIONAL ANALYSIS FOR CHEILECTOMY MARKET

The Americas dominate the global cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.

Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.

For exclusive Discount Report @ https://www.marketresearchfuture.com/check-discount/5470 .

MAJOR TOC FOR CHEILECTOMY MARKET

Chapter 1.    Report Prologue   

Chapter 2.    Market Introduction   

      2.1    Definition   

      2.2    Scope of the Study   

            2.2.1    Research Objective   

            2.2.2    Assumptions   

            2.2.3    Limitations   

Chapter 3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research   

      3.3    Secondary Research   

      3.4    Market Size Estimation

Chapter 4.    Market Dynamics

      4.1    Drivers   

      4.2    Restrains

      4.3    Opportunities   

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment           

Chapter 5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers   

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants   

            5.1.4    Threat of Substitutes   

            5.1.5    Intensity of Rivalry   

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis   

      5.4    Pricing Analysis

To be continued TOC….

Inquire before Buying @ https://www.marketresearchfuture.com/enquiry/5470 .

About us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028Maharashtra, India
Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.